Alyeska Investment Group, L.P.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1453072 CHICAGO, IL

Back to AMLX Full portfolio

Position in AMLX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$18,912,149

+$16,255,691 QoQ

Shares Held

1,053,015

+40.3% QoQ

Ownership

0.945%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#22

of 207 holders

Holding Since

Dec 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Alyeska Investment Group, L.P. holds $270,329,085 across 4 Drug Manufacturers - Specialty & Generic names. AMLX ranks #3 (7.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	6,257,579	$212,006,776
2	ELAN	Elanco Animal Health Inc	1,498,380	$36,875,131
3	AMLX	Amylyx Pharmaceuticals, Inc. This page	1,053,015	$18,912,149
4	RGC	Regencell Bioscience Holdings Ltd	416,261	$2,535,029

All Filings in AMLX

Export CSV

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$18,912,149	1,053,015	+40.3%	Shares	Sole	2026-08-14
2025-03-31	$2,656,458	750,412	-8.9%	Shares	Sole	2025-05-15
2024-12-31	$3,112,527	823,420	-59.3%	Shares	Sole	2025-02-14
2024-09-30	$6,555,880	2,023,420	+11.0%	Shares	Sole	2024-11-14
2024-06-30	$3,464,498	1,823,420	+80.8%	Shares	Sole	2024-08-14
2024-03-31	$2,864,443	1,008,607	+739.4%	Shares	Sole	2024-05-15
2023-09-30	$2,200,074	120,157	-62.5%	Shares	Sole	2023-11-14
2023-06-30	$6,905,786	320,157	+27.3%	Shares	Sole	2023-08-14
2023-03-31	$7,376,281	251,407	+402.8%	Shares	Sole	2023-05-15
2022-12-31	$1,847,500	50,000	—	Shares	Sole	2023-02-14
No filing history on record for this holder in this stock.